LSD1/HDAC6-IN-1 |
Catalog No.GC62434 |
LSD1/HDAC6-IN-1 es un inhibidor dual activo por vÍa oral de la desmetilasa 1 especÍfica de lisina (LSD1)/histona desacetilasa 6 (HDAC6), con actividad antitumoral. LSD1/HDAC6-IN-1 se puede utilizar para la investigaciÓn del mieloma mÚltiple (MM).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2738306-38-0
Sample solution is provided at 25 µL, 10mM.
LSD1/HDAC6-IN-1 is an orally active dual inhibitor of lysine specific demethylase 1(LSD1)/Histone deacetylase 6 (HDAC6), with anti-tumor activity. LSD1/HDAC6-IN-1 can be used for the research of multiple myeloma (MM)[1].
LSD1/HDAC6-IN-1 shows superior potency in multiple MM lines[1].
LSD1/HDAC6-IN-1 is efficacy in the MM.1S xenograft model[1].
[1]. M Naveen Sadhu, et al. Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma. Bioorg Med Chem Lett. 2020 Dec 24;34:127763.
Average Rating: 5
(Based on Reviews and 18 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *